node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
ADIPOQ | Ins | ENSSTOP00000014336 | ENSSTOP00000017025 | Adiponectin, C1Q and collagen domain containing. | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.605 |
ADIPOQ | LEP | ENSSTOP00000014336 | ENSSTOP00000015183 | Adiponectin, C1Q and collagen domain containing. | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways. In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo- pituitary-adrenal hormones. In the periphery, increases basal me [...] | 0.816 |
ADIPOQ | NAMPT | ENSSTOP00000014336 | ENSSTOP00000010655 | Adiponectin, C1Q and collagen domain containing. | Nicotinamide phosphoribosyltransferase; Belongs to the NAPRTase family. | 0.544 |
ADIPOQ | PPARG | ENSSTOP00000014336 | ENSSTOP00000011453 | Adiponectin, C1Q and collagen domain containing. | Peroxisome proliferator-activated receptor gamma; Nuclear receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the nuclear receptor binds to DNA specific PPAR response elements (PPRE) and modulates the transcription of its target genes, such as acyl-CoA oxidase. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. ARF6 acts as a key regulator of the tissue-specific adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut ho [...] | 0.668 |
ADIPOQ | RETNLB | ENSSTOP00000014336 | ENSSTOP00000019963 | Adiponectin, C1Q and collagen domain containing. | Resistin like beta. | 0.621 |
C14orf93 | RETNLB | ENSSTOP00000006359 | ENSSTOP00000019963 | Chromosome 14 open reading frame 93. | Resistin like beta. | 0.452 |
CAP1 | RETNLB | ENSSTOP00000020574 | ENSSTOP00000019963 | Adenylyl cyclase-associated protein; Belongs to the CAP family. | Resistin like beta. | 0.579 |
DCN | RETNLB | ENSSTOP00000007987 | ENSSTOP00000019963 | Decorin; May affect the rate of fibrils formation. | Resistin like beta. | 0.497 |
DCN | TLR4 | ENSSTOP00000007987 | ENSSTOP00000017653 | Decorin; May affect the rate of fibrils formation. | Toll like receptor 4; Belongs to the Toll-like receptor family. | 0.914 |
IGF2 | Ins | ENSSTOP00000018700 | ENSSTOP00000017025 | Insulin like growth factor 2. | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.888 |
IGF2 | LEP | ENSSTOP00000018700 | ENSSTOP00000015183 | Insulin like growth factor 2. | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways. In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo- pituitary-adrenal hormones. In the periphery, increases basal me [...] | 0.432 |
IGF2 | RETNLB | ENSSTOP00000018700 | ENSSTOP00000019963 | Insulin like growth factor 2. | Resistin like beta. | 0.436 |
Ins | ADIPOQ | ENSSTOP00000017025 | ENSSTOP00000014336 | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Adiponectin, C1Q and collagen domain containing. | 0.605 |
Ins | IGF2 | ENSSTOP00000017025 | ENSSTOP00000018700 | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Insulin like growth factor 2. | 0.888 |
Ins | LEP | ENSSTOP00000017025 | ENSSTOP00000015183 | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways. In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo- pituitary-adrenal hormones. In the periphery, increases basal me [...] | 0.831 |
Ins | NAMPT | ENSSTOP00000017025 | ENSSTOP00000010655 | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Nicotinamide phosphoribosyltransferase; Belongs to the NAPRTase family. | 0.407 |
Ins | PPARG | ENSSTOP00000017025 | ENSSTOP00000011453 | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Peroxisome proliferator-activated receptor gamma; Nuclear receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the nuclear receptor binds to DNA specific PPAR response elements (PPRE) and modulates the transcription of its target genes, such as acyl-CoA oxidase. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. ARF6 acts as a key regulator of the tissue-specific adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut ho [...] | 0.683 |
Ins | RETNLB | ENSSTOP00000017025 | ENSSTOP00000019963 | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Resistin like beta. | 0.436 |
Ins | TLR4 | ENSSTOP00000017025 | ENSSTOP00000017653 | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | Toll like receptor 4; Belongs to the Toll-like receptor family. | 0.414 |
LEP | ADIPOQ | ENSSTOP00000015183 | ENSSTOP00000014336 | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways. In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo- pituitary-adrenal hormones. In the periphery, increases basal me [...] | Adiponectin, C1Q and collagen domain containing. | 0.816 |